Zenith Drugs is a pharmaceutical manufacturing and trading company based out of Indore. They have a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing medicines. They are specialized in manufacturing high-quality and affordable Medicines to support their patients in need. The Company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception, the company has focused on building a strong foundation and laying the groundwork for its future growth and success. With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry.
The Company was incorporated with the objective of better service deliverance in the field of medicine and being a better premium pharmaceutical company in India and abroad for cost-effective human medicine. The Company always emphasizes core strengths and policies that focus on technology and great deliverance. With a passion for setting high standards of services, the company has always taken all measures to scale up as and when required only to deliver the best. They work diligently and have a wide range of products to cater to every need and to reach the client’s sensitivity and centricity.
They are proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization. Their commitment to quality is further demonstrated by their ISO 9001:2015 certification, obtained from a respected EuroUK certification body. Zenith offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules.
Navi Finserv NCD February 2024 Details
| NCD Issue Open | February 26, 2024 |
| NCD Issue Close | March 7, 2024 |
| NCD Issue Size | Base: 300 Cr. | Shelf: 600 Cr. |
| Price Band | ₹1,000 per NCD |
| Interest Rate | Up to 11.19% ** (Annually) |
| Minimum Investment | 10 Bonds (₹10,000) |
| Listing on | BSE, NSE Platform |
| Credit Rating | CRISIL A/Stable by CRISIL. |
| Tenor | 18, 27 and 36 months |
| Basis of Allotment | First Come First Serve Basis |
| DRHP Document | Click Here |
| RHP Document | Click Here |
Navi Finserv NCD February 2024 Promoters
- The Company has no identifiable promoters and is a professionally managed company.
How to Apply Navi Finserv NCD February 2024 Issue?
You can apply from your existing Demat account online and offline. You can apply by downloading the form from the official website and filling up all the details with the cheque for the said amount. You can submit it to the collection centers.
Navi Finserv NCD Review
- May Apply
Navi Finserv NCD February 2024 Tenure & Interest Rates
| Opt | Tenure | Payment | Coupon | Eff. Yield |
| 1 | 18 Month | Month | 10.00% | 10.47% |
| 2 | 27 Month | Month | 10.40% | 10.91% |
| 3 | 27 Month | Annual. | 10.90% | 10.94% |
| 4 | 36 Month | Month | 10.65% | 11.19% |
| 5 | 36 Month | Annual. | 11.19% | 11.19% |
Navi Finserv NCD Allocation Ratio
| Category | Allocation |
| Institutional | 20% |
| Non-Institutional | 25% |
| HNI | 25% |
| Retail | 30% |
Navi Finserv NCD February 2024 Lead Manager
- Jm Financial Limited
Navi Finserv NCD February 2024 Allotment Status
- Navi Finserv NCD issue allotment available on LinkIntime.
Navi Finserv NCD February 2024 Registrar
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/initial_offer/public-issues.html
Company Information
Navi Finserv Limited
Second Floor, Vaishnavi Tech Square,
Iballur Village, BegurHobli,
Bengaluru, Karnataka – 560 102
Phone: 080 45113400
Email: [email protected]
Website: http://www.navi.com/finserv
